Patent · US Active

Compositions including triciribine and taxanes and methods of use thereof

US9101641B2 · kind B2 · utility

0Cited by

23References

17Claims

0Family size

Assignee

University of South Florida · US

Inventors

Jin Q. Cheng · Tampa, US
Said M. Sebti · Tampa, US

Key dates

Filing date	Nov 26, 2013
Grant date	Aug 11, 2015
Priority date	—
Expiry date	Nov 26, 2033

Classification

Technology area (CPC G)Physics
CPC primaryG01N2333/912
WIPO fieldPharmaceuticals
WIPO sectorChemistry

Abstract

This application relates to combination therapies including triciribine and related compounds and taxanes and compositions with reduced toxicity for the treatment and prevention of tumors, cancer, and other disorders associated with abnormal cell proliferation.

Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.